Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1710-1492
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis ; volume:17 ; number:1 ; day:9 ; month:12 ; year:2021 ; pages:1-8 ; date:12.2021
Allergy, asthma and clinical immunology ; 17, Heft 1 (9.12.2021), 1-8, 12.2021
- Creator
-
Ellis, Anne K.
Gagnon, Remi
Bernstein, David I.
Nolte, Hendrik
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13223-021-00626-2
- URN
-
urn:nbn:de:101:1-2022021118301145319609
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ellis, Anne K.
- Gagnon, Remi
- Bernstein, David I.
- Nolte, Hendrik
- SpringerLink (Online service)
Other Objects (12)
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study
Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada
Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
Clinical relevance of pre- and coseasonal sublingual immunotherapy with a 300 index of reactivity 5-grass SLIT tablet in allergic rhinoconjunctivitis
Allergic sensitization in Canadian chronic rhinosinusitis patients
Poster 2022: Sublingual immunotherapy in the treatment of allergic rhinitis: series of cases
Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series
Efficacy and safety of standardized short ragweed sublingual immunotherapy tablet (SLIT-T) treatment in Canadian subjects with ragweed pollen-induced rhinitis with or without conjunctivitis
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study
Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada
Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
Clinical relevance of pre- and coseasonal sublingual immunotherapy with a 300 index of reactivity 5-grass SLIT tablet in allergic rhinoconjunctivitis
Allergic sensitization in Canadian chronic rhinosinusitis patients
Poster 2022: Sublingual immunotherapy in the treatment of allergic rhinitis: series of cases
Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series
Efficacy and safety of standardized short ragweed sublingual immunotherapy tablet (SLIT-T) treatment in Canadian subjects with ragweed pollen-induced rhinitis with or without conjunctivitis
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study
Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada
Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
Clinical relevance of pre- and coseasonal sublingual immunotherapy with a 300 index of reactivity 5-grass SLIT tablet in allergic rhinoconjunctivitis
Allergic sensitization in Canadian chronic rhinosinusitis patients
Poster 2022: Sublingual immunotherapy in the treatment of allergic rhinitis: series of cases
Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series